Company Filing History:
Years Active: 2007
Title: Shanjin Yang: Innovator in Cancer Therapy
Introduction
Shanjin Yang is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of cancer therapy through his innovative research and development of new compounds.
Latest Patents
Shanjin Yang holds one patent that focuses on the processes of preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3H-[ring fused indol-5-yl(amine-derived)] compounds. This invention is aimed at creating compounds that can be used as cytotoxins for cancer therapy and as prodrugs for gene-directed enzyme-prodrug therapy (GDEPT) and antibody-directed enzyme-prodrug therapy (ADEPT).
Career Highlights
Shanjin Yang is associated with Auckland Uniservices Limited, where he continues to advance his research in the field of medicinal chemistry. His work is pivotal in developing new therapeutic strategies for cancer treatment.
Collaborations
He has collaborated with esteemed colleagues such as William Alexander Denny and Graham John Atwell, contributing to a rich environment of innovation and research.
Conclusion
Shanjin Yang's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions are vital for the advancement of therapeutic options available to patients.